Tags: Drug.

Tesamorelin (trade name Egrifta) is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy. Tesamorelin is produced and developed by Theratechnologies Inc. of Canada.Tesamorelin is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group.

ATC prefix
H01
ATC suffix
AC06
CAS number
901758-09-6
FDA UNII code
MQG94M5EEO
PubChem
16137828

Loading...

This page contains content from the copyrighted Wikipedia article "Tesamorelin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.